A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Clinical trial NCT07286318 · RECRUITING

Trial details

NCT number: NCT07286318
Sponsor: Marissa Lobl
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Skin Cancer Cutaneous Squamous Cell Carcinoma (CSCC)Actinic Keratosis (AK)Organ Transplant Recipient

Start date: 2026-05-01
Primary completion: 2027-05-28
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.